Two of the studies included in this review [34,35] reported results for p16INK4a immunostaining in penile cancer, suggesting that only a minority of cases with LR-HPV were positive for this marker, which was in line with their limited ability to induce the degradation of pRb family proteins. This evidence concerns the gene CDKN2A and penile cancer.